Aims: Body fat accumulation is implicated in the development of cardiovascular disease (CVD). Our objective was to explore potential associations between anthropometric indices and the 10-year CVD incidence in Greek adults without previous CVD. Methods: During 2001–2, we enrolled 3042 adults without CVD from the general population of Attica, Greece. In 2011–2, the 10-year study follow-up was performed, recording the CVD incidence in 1958 participants with baseline body mass index (BMI) ≥18.5 kg/m2. Results: The study 10-year CVD incidence was 15.8%, exhibiting a gradual increase according to the baseline body mass index (BMI) category. Baseline BMI ≥30 kg/m2 was related with significantly higher 10-year CVD risk compared to BMI <25 kg/m2, e...
Aims: To evaluate the influence of metabolic syndrome (MetS) as well as inflammatory and renal marke...
Purpose: Adiponectin is an adipokine with anti-inflammatory and cardiovascular-protective properties...
Aims: Body mass index (BMI) and waist circumference (WC) are both predictors of cardiovascular disea...
Aims: Body fat accumulation is implicated in the development of cardiovascular disease (CVD). Our ob...
Background and aims: Visceral adiposity index (VAI) has been proposed as a marker of visceral adipos...
Background and aims The lipid accumulation product (LAP) is an index describing lipid over-accumulat...
Objectives: To evaluate the association of predicted lean and fat mass on 10-year first and recurren...
Background: Visceral adiposity index (VAI) is a novel marker of visceral adipose tissue accumulation...
Background Visceral adiposity index (VAI) is a novel marker of visceral adipose tissue accumulation...
The association between lipoprotein (a) (Lp(a)) and 10-year first fatal/nonfatal cardiovascular dise...
The aim of the study was to examine the effects of physical activity (PA) level on 10-year cardiovas...
To estimate trends in anthropometric indexes from 1992 to 2008 and to evaluate the risk of cardiovas...
Aims: To evaluate the influence of metabolic syndrome (MetS) as well as inflammatory and renal marke...
Purpose: Adiponectin is an adipokine with anti-inflammatory and cardiovascular-protective properties...
Aims: Body mass index (BMI) and waist circumference (WC) are both predictors of cardiovascular disea...
Aims: Body fat accumulation is implicated in the development of cardiovascular disease (CVD). Our ob...
Background and aims: Visceral adiposity index (VAI) has been proposed as a marker of visceral adipos...
Background and aims The lipid accumulation product (LAP) is an index describing lipid over-accumulat...
Objectives: To evaluate the association of predicted lean and fat mass on 10-year first and recurren...
Background: Visceral adiposity index (VAI) is a novel marker of visceral adipose tissue accumulation...
Background Visceral adiposity index (VAI) is a novel marker of visceral adipose tissue accumulation...
The association between lipoprotein (a) (Lp(a)) and 10-year first fatal/nonfatal cardiovascular dise...
The aim of the study was to examine the effects of physical activity (PA) level on 10-year cardiovas...
To estimate trends in anthropometric indexes from 1992 to 2008 and to evaluate the risk of cardiovas...
Aims: To evaluate the influence of metabolic syndrome (MetS) as well as inflammatory and renal marke...
Purpose: Adiponectin is an adipokine with anti-inflammatory and cardiovascular-protective properties...
Aims: Body mass index (BMI) and waist circumference (WC) are both predictors of cardiovascular disea...